RIG012

CAS No. 2642218-43-5

RIG012( —— )

Catalog No. M36533 CAS No. 2642218-43-5

RIG012 is a potent RIG-I inhibitor with an IC50 of 0.71 μM (measured by NADH-coupled ATPase), and it inhibits the expression of IFN-β and ISG hRsad2.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 176 In Stock
5MG 275 In Stock
10MG 440 In Stock
25MG 702 In Stock
50MG 908 In Stock
100MG 1242 In Stock
500MG 2502 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    RIG012
  • Note
    Research use only, not for human use.
  • Brief Description
    RIG012 is a potent RIG-I inhibitor with an IC50 of 0.71 μM (measured by NADH-coupled ATPase), and it inhibits the expression of IFN-β and ISG hRsad2.
  • Description
    RIG012 is a potent RIG-I inhibitor with an IC50 of 0.71 μM using the NADH-coupled ATPase assay. RIG012 inhibits IFN-β and ISG hRsad2 expression.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2642218-43-5
  • Formula Weight
    359.42
  • Molecular Formula
    C23H21NO3
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 33.33 mg/mL (92.73 mM; Ultrasonic )
  • SMILES
    C(C)C1(CC)C=2C(C=3C(C(=O)C2OCC4=CC=CC=C4)=CC=CC3)=NC1=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. David C Rawling, et al. Small-Molecule Antagonists of the RIG-I Innate Immune Receptor. ACS Chem Biol. 2020 Feb 21;15(2):311-317.?
molnova catalog
related products
  • 4-Amino-5-Chloro-2-M...

    Used as organic synthesis and medicine intermediate.

  • 5,6,7-Trimethoxycoum...

    5,6,7-Trimethoxycoumarin shows moderate inhibitory activity against Micrococcus luteus, it also displays an intermediate cytotoxic effects against brine shrimp larvae. 5,6,7-Trimethoxycoumarin can improve gastroprotective effects, and it has low toxicity and minimal effects on drug-metabolizing enzymes.

  • Ac-GPK-pNA

    Ac-GPK-pNA